These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

631 related items for PubMed ID: 11408737

  • 1. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV, Pecorelli S, Radominska-Pandya A, Cannon MJ, Parham GP.
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [Abstract] [Full Text] [Related]

  • 2. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 3. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
    Santin AD, Bellone S, Palmieri M, Bossini B, Cane' S, Bignotti E, Roman JJ, Cannon MJ, Pecorelli S.
    Int J Gynecol Cancer; 2004 Jun; 14(1):64-75. PubMed ID: 14764031
    [Abstract] [Full Text] [Related]

  • 4. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A, Rogala E, Bednarek W, Barczyński B, Wertel I, Piekarczyk W, Kotarski J.
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [Abstract] [Full Text] [Related]

  • 5. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE, Van Gool SW, Van Poppel H, Baert L, Coorevits L, Van Damme B, Ceuppens JL.
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [Abstract] [Full Text] [Related]

  • 6. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
    Santin AD, Bellone S, Palmieri M, Bossini B, Roman JJ, Cannon MJ, Bignotti E, Canè S, Pecorelli S.
    Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
    [Abstract] [Full Text] [Related]

  • 7. The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
    Melichar B, Tousková M, Tosner J, Kopecký O.
    Onkologie; 2001 Apr; 24(2):156-60. PubMed ID: 11441296
    [Abstract] [Full Text] [Related]

  • 8. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY, Staren ED, Tereshkova N, Braun DP.
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [Abstract] [Full Text] [Related]

  • 9. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours.
    Schöndorf T, Engel H, Lindemann C, Kolhagen H, von Rücker AA, Mallmann P.
    Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470
    [Abstract] [Full Text] [Related]

  • 10. Flow cytometric analysis of tumour-infiltrating lymphocytes in patients with renal cell carcinoma.
    Kowalczyk D, Skorupski W, Kwias Z, Nowak J.
    Br J Urol; 1997 Oct; 80(4):543-7. PubMed ID: 9352689
    [Abstract] [Full Text] [Related]

  • 11. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.
    Int J Radiat Oncol Biol Phys; 2002 Dec 01; 54(5):1345-55. PubMed ID: 12459356
    [Abstract] [Full Text] [Related]

  • 12. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL.
    Clin Cancer Res; 1996 Jan 01; 2(1):161-73. PubMed ID: 9816103
    [Abstract] [Full Text] [Related]

  • 13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 01; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 14. Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.
    Elsässer-Beile U, Rindsfüser M, Grussenmeyer T, Schultze-Seemann W, Wetterauer U.
    Br J Cancer; 2000 Sep 01; 83(5):637-41. PubMed ID: 10944605
    [Abstract] [Full Text] [Related]

  • 15. T-cell recognition of ovarian cancer.
    Peoples GE, Schoof DD, Andrews JV, Goedegebuure PS, Eberlein TJ.
    Surgery; 1993 Aug 01; 114(2):227-34. PubMed ID: 8342128
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion.
    Elsässer-Beile U, Wetterauer U, Schultze-Seemann W, Gallati H, Mönting JS, von Kleist S.
    Cancer Immunol Immunother; 1996 Feb 01; 42(2):93-8. PubMed ID: 8620526
    [Abstract] [Full Text] [Related]

  • 17. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.
    Matsuda M, Petersson M, Lenkei R, Taupin JL, Magnusson I, Mellstedt H, Anderson P, Kiessling R.
    Int J Cancer; 1995 Jun 09; 61(6):765-72. PubMed ID: 7790109
    [Abstract] [Full Text] [Related]

  • 18. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
    Daniel V, Naujokat C, Sadeghi M, Weimer R, Renner F, Yildiz S, Opelz G.
    Transpl Int; 2008 Jul 09; 21(7):646-60. PubMed ID: 18298587
    [Abstract] [Full Text] [Related]

  • 19. High expression of adhesion molecules/activation markers with little interleukin-2, interferon gamma, and tumor necrosis factor beta gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma.
    Roussel E, Gingras MC, Grimm EA, Roth JA.
    Cancer Immunol Immunother; 1995 Jul 09; 41(1):1-9. PubMed ID: 7641214
    [Abstract] [Full Text] [Related]

  • 20. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.
    Cancer Res; 2001 Jun 15; 61(12):4766-72. PubMed ID: 11406550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.